Welcome to Our Blog

Subscribe below to get free access to our latest newsletter and watch our product video

Semalytix’ and Boehringer Ingelheim’s innovative social media study on the parental experience around Crohn’s disease wins EphMRA award

A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a...


( read )

Tags: Semalytix, Pharma, PatientListening,

Leveraging Patient-Focused Drug Development by Social Media Patient Listening Studies
Philipp Cimiano (Chief Technology Officer)
Matthias Hartung (Chief Research Officer)
Jens Höwelkröger (Product Manager)

( read )

Tags: Semalytix, AI, Healthcare,

Are you listening? Patients will tell you what a good drug looks like.

Patients’ voices are no longer a nice-to-have in drug development. They are a critical determinant of commercial success. As...


( read )

Tags: Semalytix, "patient listening", "Health"

White Paper: AI-Powered Real-World Evidence Generation

Improving Pharma’s Ability to Focus on the Needs of Key Stakeholders

Executive Summary


( read )

Tags: Paper, Semalytix, AI

How machines can measure the real impact of new therapies

By Melanie Senior, Analyst and Specialist, Writer in Pharma, Life Sciences


( read )

Tags: Semalytix

Semalytix’ Knowledge Graph featured at the Neo4J Meeting „GraphTalk: Health & Life Sciences“ in Basel

The knowledge graph developed by Semalytix comprises of millions of pharma-relevant entities modeling key knowledge about...


( read )

Tags: Semalytix

Pharma Pricing & Market Access (PPMA) Conference Learnings

Looking at Market Access for the pharmaceutical industry through the eyes of somebody involved in machine learning and...


( read )

Tags: Semalytix

Paper on „Zero-Shot Cross-Lingual Opinion Target Extraction“ at NAACL 2019

At Semalytix, we are developing cutting-edge technology for machine reading, allowing machines to automatically sift through...


( read )

Tags: Semalytix